Blood level of neurofilament light chain as a biomarker for neurological disorders
Saved in:
Main Authors: | Martin R Turner, Charlotte E Teunissen, Alexander G Thompson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Medicine |
Online Access: | https://bmjmedicine.bmj.com/content/4/1/e000958.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of neurofilament light chain in the context of neurological disorders
by: V. Taluntienė, et al.
Published: (2020-12-01) -
Neurofilament light chain (Nf-L) in cerebrospinal fluid and serum as a potential biomarker in the differential diagnosis of neurological diseases in cattle
by: Giorgia Di Muro, et al.
Published: (2025-01-01) -
Plastic harmful ingredients reduce the level of neurofilament light chain protein
by: Long Li, et al.
Published: (2025-01-01) -
Evaluating neurofilament light chain serum levels as a diagnostic marker for Lyme neuroborreliosis
by: Cédric Hirzel, et al.
Published: (2025-01-01) -
Elevated serum neurofilament light chain levels in patients with neuropsychiatric systemic lupus erythematosus: a cross-sectional study
by: Karel Pavelka, et al.
Published: (2025-01-01)